Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation

NCT05960058 · clinicaltrials.gov ↗

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis
SARS-CoV 2 Vaccination

Sponsor

Assistance Publique - Hôpitaux de Paris